報價延遲最少15分鐘:2025/05/30 07:14 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
37.685 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-3.61/-4.53
|
|
企業價值
2.13B
|
| 資產負債 |
|
每股賬面淨值
11.55
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/05/30 07:14 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties. |